HLS Therapeutics (HLS) AGM 2026 summary

Opening remarks and agenda

• Meeting opened with a welcome and explanation of virtual format, ensuring equal participation and voting rights for all shareholders and proxy holders regardless of location.

• Attendees were introduced, including key officers and nominees for Director positions.

• The agenda included presentation of financial statements, election of Directors, reappointment of the Auditor, and approval of the Long-Term Incentive Plan.

Board and executive committee updates

• Eight nominees for Director positions were introduced and nominated, with no further nominations permitted per bylaws.

• The Board and executive team were present and available for questions during the meeting.

Shareholder proposals

• Four formal items of business were presented: financial statements, election of Directors, reappointment of Auditor, and approval of the Long-Term Incentive Plan.